BACTEREMIA POR PSEUDOMONAS AERUGINOSA PRODUTORA DE VIM COMO COMPLICAÇÃO APÓS O CAR-T-CELL
Uma estratégia moderna e eficaz para tratar neoplasias hematológicas refratárias é a modificação genética de células T autólogas para expressar um receptor quimérico de antígeno contra as células tumorais, o CAR-T-cell. Existem poucos dados sobre complicações infecciosas de CAR-T-cell, sem guias de...
Main Authors: | Eusébio Lino dos Santos Júnior, Erick Menezes Xavier, Hermes Ryoiti Higashino, Vanderson Geraldo Rocha, Silvia Figueiredo Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867023005020 |
Similar Items
-
Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids in Pseudomonas aeruginosa
by: Nanfei Wang, et al.
Published: (2023-10-01) -
The Frequency of VIM 2, 3, 9, 11 and VIM all among Metallo-beta-Lactamase Producing Pseudomonas aeruginosa
by: Rahele Naserian Moghadam, et al.
Published: (2018-11-01) -
Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care
by: Gaud Catho, et al.
Published: (2021-08-01) -
Spread of VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from Iaşi, Romania
by: Mereuţă Ana Irina, et al.
Published: (2013-12-01) -
Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis
by: Mansour Sedighi, et al.
Published: (2014-01-01)